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Abstract: Epidemiologic studies can measure exposure to volatile organic compounds (VOCs)
using environmental samples, biomarkers, questionnaires, or observations. These different
exposure assessment approaches each have advantages and disadvantages; thus, evaluating
relationships is an important consideration. In the National Children’s Vanguard Study from
2009 to 2010, participants completed questionnaires and data collectors observed VOC exposure
sources and collected urine samples from 488 third trimester pregnant women at in-person
study visits. From urine, we simultaneously quantified 28 VOC metabolites of exposure to
acrolein, acrylamide, acrylonitrile, benzene, 1-bromopropane, 1,3-butadiene, carbon disulfide,
crotonaldehyde, cyanide, N,N-dimethylformamide, ethylbenzene, ethylene oxide, propylene oxide,
styrene, tetrachloroethylene, toluene, trichloroethylene, vinyl chloride, and xylene exposures using
ultra high performance liquid chromatography coupled with an electrospray ionization tandem
mass spectrometry (UPLC-ESI/MSMS) method. Urinary thiocyanate was measured using an
ion chromatography coupled with an electrospray ionization tandem mass spectrometry method
(IC-ESI/MSMS). We modeled the relationship between urinary VOC metabolite concentrations
and sources of VOC exposure. Sources of exposure were assessed by participant report via
questionnaire (use of air fresheners, aerosols, paint or varnish, organic solvents, and passive/active
smoking) and by observations by a trained data collector (presence of scented products in homes).
We found several significant (p < 0.01) relationships between the urinary metabolites of VOCs
and sources of VOC exposure. Smoking was positively associated with metabolites of the
tobacco constituents acrolein, acrylamide, acrylonitrile, 1,3-butadiene, crotonaldehyde, cyanide,
ethylene oxide, N,N-dimethylformamide, propylene oxide, styrene, and xylene. Study location
was negatively associated with the toluene metabolite N-acetyl-S-(benzyl)-L-cysteine (BMA), and
paint use was positively associated with the xylene metabolites 2-methylhippuric acid (2MHA) and
3-Methylhippuric acid & 4-methylhippuric acid (3MHA + 4MHA). A near-significant (p = 0.06)
relationship was observed between acrylamide metabolites and observation of incense.
Keywords: birth cohort study; pregnant women; tobacco; volatile organic compounds; urinary
metabolites; National Children’s Study
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1. Introduction
Volatile organic compounds (VOCs) are compounds with low boiling points; VOC exposures
originate from numerous natural and anthropogenic sources such as cleaning products, paints, solvents,
personal care products, automotive exhaust, and tobacco smoke [1–3]. Exposure to certain VOCs
may increase the risk for birth defects, neurocognitive impairment, asthma, and cancer [4–7]. Due to
these health concerns and ubiquitous exposure, the impact of exposure to VOCs on child health and
development is often studied [8–10]. Table 1 lists some common exposure sources for selected VOCs.
Table 1. Common exposure sources of selected volatile organic compounds (VOCs).
VOC Compound Common Exposure Sources
Acrolein Tobacco smoke, combustion of petroleum fuels, industries where acrolein is used, cookingoil, endogenous [11,12].
Acrylamide
Tobacco smoke, eating carbohydrate-rich foods that are cooked at high temperatures,
contaminated well-water, working in the production or use of acrylamide and acrylamide
containing products (exposure may occur through skin contact) [11–13].
Acrylonitrile Tobacco smoke, industrial sources or hazardous waste sites [11–13].
Benzene Tobacco smoke, automobile service stations, exhaust from motor vehicles, and industrialemissions [11–13].
1-Bromopropane Dry-cleaning, metal-degreasing solvent [11,13].
1,3-Butadiene Tobacco smoke, vehicle exhaust, waste incineration, or wood fires, drinking contaminatedwater near production or waste sites [11–13].
Carbon disulfide Tobacco smoke, manufacturing processing [11,12].
Crotonaldehyde Tobacco smoke, gasoline and diesel engine exhausts, and smoke from wood burning,naturally occur in some foods [11,12].
N,N-Dimethylformamide Tobacco smoke, building materials, glues [11,12].
Ethylbenzene Tobacco smoke, burning fossil fuels, industries using ethylbenzene, carpet glues, varnishes,and paints [11,12].
Ethylene oxide Tobacco smoke, occupational exposure, through use in hospital sterilization or use as apesticide [11–13].
Hydrogen cyanide Tobacco smoke, food, manufacturing processes, endogenous [11,12].
Propylene oxide Tobacco smoke, occupational exposure, plastics industry [11–13].
Styrene Tobacco smoke, vehicle exhaust, building materials, manufacturing, foods packaged inpolystyrene containers [11–13].
Toluene Tobacco smoke, fossil fuels, industrial solvent, paints, paint thinners [11,12]
Tetrachloroethylene Dry-cleaning, metal degreasing solvent, contaminant detected at superfund sites, surfaceand groundwater contaminant [13].
Trichroloethylene Dry-cleaning, industrial solvent [13].
Vinyl chloride Tobacco smoke, breathing contaminated air from plastics industries, hazardous waste sites,and landfills. Drinking water from contaminated wells [11–13].
Xylene Tobacco smoke, gasoline, paint, varnish, shellac, rust preventatives [11–13].
Epidemiologic studies designed to evaluate these research questions can use a variety of exposure
assessment methods, such as questions about use of products or behaviors that may increase
exposure to certain VOCs, measurement of VOCs in blood, measurement of metabolites in urine, and
measurement of VOCs in indoor air. Each of these exposure assessment methods has advantages and
disadvantages. Questionnaires are inexpensive to administer, but when used as the sole source of
exposure assessment, their accuracy is dependent on participant recall and knowledge of participant
behavior [14,15]. Observations of VOC sources in homes by trained data collectors are not subject to
recall bias, but are limited in that some household characteristics may be modified by the participant
prior to the study home visit. Blood VOCs provide a scientifically sound basis to extract a dose
response, but have very short biological half-lives [3,16]. Metabolites of VOCs in urine have a longer
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biological half-life than VOCs in blood and are more stable during storage and handling, but most
metabolites still have half-lives of less than two days and thus some intermittent exposures may be
missed [3]. Assessment of exposure to VOCs by sampling air has been completed in many studies,
but pharmacologic and physiologic parameters need to be accounted for in sophisticated models to
estimate internal absorbed dose [16].
The U.S. National Children’s Study (NCS), a planned longitudinal cohort study that was to
recruit participants from across the United States from before birth through age 21, measured exposure
to VOCs [17,18]. During the initial phase of the Vanguard Study from 2009 to 2010, a variety of
methods both indirect and direct were included to assess exposure to VOCs: Indirect methods,
questionnaires and observations of VOC sources in the home. Direct methods refer to, measurement of
VOC metabolites in urine, and measurement of VOCs in air and water in a subsample of homes [18].
In this paper we compare some of the indirect exposure assessments used in the NCS with the
measurement of metabolites of VOCs in urine. Several other studies have compared indirect methods
of estimating VOC exposure with VOC measurements in blood or air [1,19–22], but this is the first
study to compare these methods with a large panel of urinary metabolites of VOC exposure.
2. Methods
2.1. Study Population
As described elsewhere [18,23,24], 1399 women were enrolled in the NCS initial Vanguard Study
from 2009 to 2010 from seven locations: Queens County, New York; Duplin County, North Carolina;
Salt Lake County, Utah; Orange County, California; Montgomery County, Pennsylvania; Waukesha
County, Wisconsin; and four adjacent counties in South Dakota and Minnesota (Brookings County, SD;
Yellow Medicine County, MN; Pipestone County, MN; Lincoln County, MN) [14]. Enrolled women
could have completed at least one of several different types of study visits during the NCS initial
Vanguard Study: pre-pregnancy visit (P1), first trimester visit (T1), third trimester visit among women
who had a prior study visit (T3-Prior), and third trimester visit among women who did not have a
prior study visit (T3-First). All home visits included environmental sample collections such as air,
water and dust [18], an interview, collection of biospecimens, and a physical exam. P1, T1, and T3-First
visits also included an observational walk-through of the residence. Participants could refuse any
portion of a study visit. There were a total of 488 unique participants with interviews, observations,
and urine VOCs results: 344 had T3-Prior visits, and 144 had T3-First visits.
All biospecimens were collected in accordance with pre-tested standard operating procedures
which were the same at all study locations [25]. A portion of biospecimens collected during the initial
Vanguard Study was analyzed through a collaborative pilot study between the NCS and the Centers
for Disease Control and Prevention (CDC) [26,27]. In this collaborative pilot, biomarkers of exposure
to environmental chemicals were measured (Environmental Health Laboratory, CDC) in biospecimens
collected from a sample of pregnant Vanguard Study enrollees. Most specimens used in the pilot
were obtained from the third trimester visit (T3-Prior or T3-First) and consisted of a sample of about
70 women from each study location [27].
Written informed consent was obtained from all participants and the study protocol was approved
by the NICHD Institutional Review Board (IRB) and the IRBs at each Vanguard Study institution
(NICHD IRB protocol number 09-CH-N083). The involvement of the CDC laboratory was determined
not to constitute engagement in human subjects research, and thus was not reviewed by the CDC IRB.
2.2. Urine Collection and Analysis
All urine analytes were measured in aliquots of spot urine samples that were collected at study
visits into pre-screened, metal-free containers. Urine samples were shipped frozen to the NCS Biological
and Environmental Sample Repository (Fisher Bioservices; Rockville, MD, USA), where they were
aliquoted and frozen at ´150 ˝C. Samples were shipped to the CDC for analysis on dry ice and stored
Int. J. Environ. Res. Public Health 2016, 13, 376 4 of 16
locally at ´20 ˝C until they were analyzed. The urine aliquots were analyzed simultaneously for
28 urinary VOC metabolites using an ultra high performance liquid chromatography coupled with
an electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS) method [3]. The limits of
detection of this method range from 0.5 to 20 ng/mL. The 28 metabolites are biomarkers of exposure
to acrolein, acrylamide, acrylonitrile, benzene, 1-bromopropane, 1,3-butadiene, carbon disulfide,
crotonaldehyde, hydrogen cyanide, N,N-dimethylformamide, ethylbenzene, ethylene oxide, propylene
oxide, vinyl chloride, styrene, tetrachloroethylene, toluene, trichloroethylene, and xylene. All of
these parent compounds are tobacco smoke constituents, with the exception of 1-bromopropane,
tetrachloroethylene, and trichloroethylene. The metabolite for cyanide measured by the urine
VOC method, 2-aminothiazoline-4-carboxylic acid, is not specific for hydrogen cyanide exposure,
thiocyanate (SCN), a more specific biomarker for hydrogen cyanide, was measured using a quantitative
procedure for the measurement of nitrate, perchlorate, and thiocyanate in human urine using
ion chromatography coupled with electrospray tandem mass spectrometry [28]. Urine creatinine
was measured on a Roche/Hitachi Modular P Chemistry Analyzer, using a method similar to the
one employed in the National Health and Nutrition Examination Survey [29].
2.3. Blood Collection and Analysis
Blood specimens were collected by trained phlebotomists in the home or clinic, into no-additive
serum red top tubes (Becton Dickinson; Franklin Lakes, NJ, USA) for serum cotinine. Samples were
centrifuged locally at ambient temperature within 2 h of collection and shipped on ice packs to the
repository. There red top tubes were re-spun and aliquotted into pre-screened metal-free cryovials.
Aliquots were stored at vapor phase liquid nitrogen temperature (´150 ˝C) until shipment on dry ice
to the CDC. Serum cotinine was analyzed by the CDC’s tobacco exposure biomarkers laboratory using
a standard method with a limit of detection of 0.015 ng/mL [30,31].
2.4. Questionnaire and Observation Data
The home observation form that was completed by a trained data collector at the P1, T1, and
T3-First visits contained the following observations related to VOC exposure: air freshener; incense;
candles; and other scented products (heavily scented soaps, etc.). Since the observations were not
conducted at the T3-Prior visit, if the urine collected came from a T3-Prior visit, we used the observation
data from the participant’s T1 visit.
At all visits, the interview contained a traditional data collector-led portion and an Audio Assisted
Computer Self-Interview (ACASI). The data collector-led portion at the third trimester visits (T3-Prior
and T3-First) asked participants about the use of products over the last three months that may contain
or off-gas VOCs such as air fresheners, other aerosols, paint or varnish, paint thinners and other
organic solvents. The ACASI interview asked about current smoking, the number of cigarettes per day,
and hours around smoking. The T1 interview also included a question about the frequency of gas
pumping. Thus, questionnaire items that were assessed at the same visit that the urine was collected
include: current smoking and the reported use of VOC-containing products (i.e., air fresheners, other
aerosols, paint or varnish, paint thinners and other organic solvents).
Following all third trimester visits, the participants were asked to complete a three-day time, place
and activity diary based on the diary used in the National Human Exposure Assessment Survey [32].
This diary was a self-administered, paper diary which was completed for three consecutive days,
always including a weekend day and two weekdays. Each diary day was divided into half-hour
intervals. The participant recorded her activity and location during each interval. From this diary data
we created an average cooking time variable.
2.5. Statistical Methods
For this analysis, we modeled the relationship between the predictor variables and the
concentration of the VOC metabolites, using a linear regression of log10 VOC (all predictor
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variables were used in each regression as main effects, i.e., no interactions). We used maximum
likelihood estimation (MLE) via the LIFEREG procedure in SAS vs. 9.1 (Cary, NC, USA) to
account for left-censored data (i.e., data below the limit of detection (LOD)) [33]. The urinary VOC
metabolite data were highly right skewed (approximating a log-normal distribution), therefore a
log10 transformation was applied. Concentrations of the six metabolites with very low percent
detection (<25%) were not modeled, i.e., N-acetyl-S-(1,2-dicholorovinyl)-L-cysteine (1DCVMA),
N-acetyl-S-(2,2-dicholorovinyl)-L-cysteine (2DCVMA), N-acetyl-S-(trichlorovinyl)-L-cysteine (TCVMA),
N-acetyl-S-(2,4-dimethylphenyl)-L-cysteine (DPMA), N-acetyl-S-(1-hydroxymethyl-2-propenyl)-
L-cysteine (MHBMA1), N-acetyl-S-(2-hydroxy-3-butenyl)-L-cysteine (MHBMA2).
The 22 urinary log10 metabolite concentrations were used as dependent variables in regressions
which included log10 creatinine as a predictor variable [34]. We chose which interview and observation
variables to include in each model as predictor variables, based on knowledge of sources of exposure to
the parent compounds and predictor variables remained in the final models regardless of significance.
Model variables were handled in the following ways: study location was categorized as urban
(Queens County, NY; Orange County, CA; Salt Lake City, UT; and Montgomery County, PA) vs. rural
(South Dakota and Minnesota, Duplin County, NC; and Waukesha County, WI) based on the approach
used in Boyle et al., 2015 [18]. Observations of air fresheners, scented candles, and other scented
products were categorized as present or not present. An indicator variable (i.e., visit type) was used to
indicate participants with first trimester visits or third trimester visits. Reported use of air fresheners,
other aerosols, and paint/varnish, was categorized as every day, some days, or not at all/refused. Paint
thinner and turpentine use were not included in the final models because use was rare (less than 1%)
and all such users also used paint.
Smoking exposure was assigned based on both self-reported smoking status from the interview
and serum cotinine. From the interview data, smokers and non-smokers were categorized into
three mutually exclusive smoking categories: heavy smokers (10 or more cigarettes per day), moderate
smokers (less than 10 cigarettes per day), and non-smokers. Self-reported smokers (moderate and
heavy) and subjects with high serum cotinine levels (>3.0 ng/mL) were classified as smokers similar
to the approach used with non-pregnant reference populations [35]. Non-smokers were classified




Table 2 shows the VOC-related characteristics considered in regressions for the NCS
2009´2010 year among participants with non-missing urine VOCs samples (n = 488). The results were
similar when the sample included participants with missing urine VOCs measurements. Among the
four ”observed” variables, candles were most frequently observed (51.4%) while incense was least
frequently observed in households (6.2%). Among the self-reported VOC categories, air fresheners
were used by 72.3% of participants over the last three months, while 23.6% reported using paints or
varnishes. Most participants reported cooking for less than one hour on average over the three time and
place diary days. Self-reported smoking behavior indicated only 27 smokers among the 488 subjects.
The population had low smoking and secondhand-smoke exposure; with only 25.8% having reported
smoking, being exposed to smoke, or having a detectable cotinine result. Finally, the study population
was close to evenly divided among rural and urban study locations.
Observed air freshener and reported air freshener use were correlated. While the correlation was
statistically significant and greater than zero (ϕ = 0.24), the correlation was not large. Self-reported
air freshener use (72.3%) was much greater than observed air freshener presence (26.8%). Therefore,
despite some potential confounding, both self-reported and observed air freshener were included in
VOC metabolite regressions.
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Table 2. Descriptive statistics of the National Children’s Study (NCS) Vanguard 2009–2010 urine VOC


















Some days 232 47.5%
Every day 0 0.0%
Reported air freshener use
No 135 27.7%
Some days 223 45.7%
Every day 130 26.6%
Reported aerosol use
No 217 44.5%
Some days 173 35.4%
Every day 98 20.1%
Reported paint/varnish use
No 373 76.4%
Some days 115 23.6%
Every day 0 0.0%
Reported paint thinner use
No 484 99.2%
Some days 4 0.8%
Every day 0 0.1%
Reported turpentine use
No 484 99.2%
Some days 4 0.8%
Every day 0 0.1%
3-day average reported cooking time
None 123 25.2%
<1 h 211 43.2%











3.2. Metabolite Detection and Distribution
Table 3 presents the detection frequency, the median, the 75th percentile, and the maximum for the
22 VOC metabolites included in the regression models. Sixteen of the 22 metabolites had a detection
frequency greater than 90%. Most VOC metabolites were highly right skewed with maximum observed
levels generally 10-fold greater than the median.
Int. J. Environ. Res. Public Health 2016, 13, 376 7 of 16
Table 3. Detection frequencies and concentration distribution for metabolites included in regression models (n = 488).
Parent VOC
Metabolite






CEMA N-Acetyl-S-(2-carboxyethyl)-L-cysteine 99 71.8 124 2260
3HPMA N-Acetyl-S-(3-hydroxypropyl)-L-cysteine 100 240 403 14,400
Acrylamide GAMA N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine 49 <9.4 * 15.61 203
AAMA N-Acetyl-S-(2-carbamoylethyl)-L-cysteine 100 33.3 55.23 582
Acrylonitrile CYMA N-Acetyl-S-(2-cyanoethyl)-L-cysteine 83 1.33 2.22 812
Benzene
PMA N-Acetyl-S-(phenyl)-L-cysteine 52 0.642 1.11 12.3
MU t,t-Muconic acid 92 245 391 4090
1-Bromopropane BPMA N-Acetyl-S-(n-propyl)-L-cysteine 99 2.61 9.44 4260
1,3-Butadiene
DHBMA N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine 100 281 431 1730
MHBMA3 N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine 94 6.90 12.1 597
Carbon disulfide TTCA 2-Thioxothiazolidine-4-carboxylic acid 66 5.91 13.3 483
Crotonaldehyde HPMMA N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine 100 342 592 17,700
N,N-Dimethylformamide AMCC N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine 100 66.6 127 2950
Ethylbenzene, styrene PGA Phenylglyoxylic acid 93 208 356 2130
Ethylene oxide, vinyl
chloride, acrylonitrile HEMA N-Acetyl-S-(2-hydroxyethyl)-L-cysteine 70 0.963 1.72 33.4
Hydrogen cyanide SCN¯ Thiocyanate 100 832 1435 19,100
Propylene oxide 2HPMA N-Acetyl-S-(2-hydroxypropyl)-L-cysteine 98 44.6 86.1 2660
Styrene MA Mandelic acid 99 208 302 2190
PHEMA N-Acetyl-S-(1-phenyl-2-hydroxyethyl)-L-cysteine +N-Acetyl-S-(2-phenyl-2-hydroxyethyl)-L-cysteine 24 <0.7 * <0.7 * 9.84
Toluene BMA N-Acetyl-S-(benzyl)-L-cysteine 99 5.62 12.1 519
Xylene 2MHA 2-Methylhippuric acid 95 21.2 41.8 3810
3MHA + 4MHA 3-Methylhippuric acid & 4-methylhippuric acid 100 150 306 17,800
* Below LOD. Parent VOC, refers to the compound that the metabolite originates from.
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3.3. Regression Results
Table 4 presents the regression results for all models. The most common significant covariate was
smoking exposure. Smoking exposure predicted (p < 0.01) all VOC metabolites which are biomarkers
of tobacco constituents except: PMA and MU (both benzene metabolites), TTCA (a carbon disulfide
metabolite), PGA (an ethylbenzene and styrene metabolite), and BMA (a toluene metabolite). Smokers
had increased VOC metabolite levels compared to subjects with none or minimal smoke exposure.
VOC metabolite levels were similar among subjects with none or little smoke exposure and subjects
with some smoke exposure (none of the 15 regressions showed statistically significant differences).
Paint or varnish use was considered a potential VOC metabolite covariate in five regressions
(MA, PHEMA, BMA, 2MHA, and 3MHA + 4MHA). Paint or varnish use was associated with
increased concentration of the xylene metabolites 2MHA and 3MHA + 4MHA. In both the 2MHA and
3MHA + 4MHA regressions participants who used paint products had increased metabolite levels
compared to subjects that never used paint products (p < 0.0001 in both regressions).
Among other observed and reported product uses, no statistically significant results were
found. Near-significant results (p = 0.06 in both regressions) were noted for observed incense use on
two acrylamide metabolites (GAMA and AAMA). Subjects with incense observed in the household
had increased GAMA and AAMA compared to subjects with no incense observed in the household.
The toluene metabolite BMA was associated with geographical location (i.e., urban v. rural
location). Concentrations of BMA among subjects living in rural PSUs were lower than those who
lived in urban PSUs (p = 0.003). An indicator variable (i.e., visit type) was included in all regressions to
account for subjects where “observed” covariates were collected at the first trimester rather than the
third trimester.
Finally, in six regressions (DHBMA, MHBMA3, CEMA, 3HPMA, GAMA, and AAMA) we looked
for a relationship between cooking and VOC exposure. In none of these regressions was cooking
exposure statistically significant. Additional covariates considered in each regression but found to be
not statistically significant are listed in Table 4.
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Smoking Reported Paint/Varnish Observed Incense Study Location
Other Considered Covariates
None Some Smoker No Yes Yes No Rural Urban
Acrolein (CEMA) 1.5 (1.3, 1.7) * ´0.68(´0.78, ´0.58) *
´0.69
(´0.79, ´0.59) * Rf — — — Rf — — Reported cooking time




(´0.52, ´0.32) * Rf — — — Rf — — Reported cooking time




(´0.54, ´0.34) * Rf — —
0.09
(´0.008, 0.19) Rf — — Observed incense




(´0.57, ´0.33) * Rf — —
0.11
(´0.0076, 0.23) Rf — — Observed incense




(´1.7, ´1.5) * Rf — — — Rf
´0.02
(´0.079, 0.039) Rf
Benzene (MU) 1.2 (0.91, 1.5) * ´0.11(´0.27, 0.047)
´0.05
(´0.23, 0.13) Rf — — — Rf
0.03
(´0.048, 0.11) Rf Reported gas pumping




(´0.26, 0.057) Rf — — — Rf
´0.01
(´0.088, 0.068) Rf Reported gas pumping
1,3´Butadiene (DHBMA) 0.87 (0.73, 1) * ´0.11(´0.17, ´0.051) *
´0.15
(´0.21, ´0.091) * Rf — —
0.04
(´0.019, 0.099) Rf — —
Observed air freshener, Observed
candles, Observed incense, Observed
other scented products, Reported air








(´1.1, ´0.89) * Rf — —
´0.06
(´0.2, 0.077) Rf — —
Observed air freshener, Observed
candles, Observed incense, Observed
other scented products, Reported air








(´0.66, 0.0032) * Rf — — 0.01 (´0.3, 0.32) Rf — — Observed incense




(´0.34, 0.096) Rf — — — Rf —
Crotonaldehyde




(´0.81, ´0.61) * Rf — — — Rf — —
Cyanide (SCN´) 2.7 (2.4, 2.9) * ´0.67(´0.79, ´0.55) *
´0.7



















(´0.7, ´0.42) * Rf — — — Rf
´0.03
(´0.089, 0.029) Rf





Smoking Reported Paint/Varnish Observed Incense Study Location
Other Considered Covariates
None Some Smoker No Yes Yes No Rural Urban
N,N´Dimethylformamide




(´0.83, ´0.63) * Rf — — — Rf — —
Propylene oxide




(´0.65, ´0.29) * Rf — — — Rf — —
Styrene (MA) 1 (0.86, 1.2) * ´0.16(´0.24, ´0.082) *
´0.18




(´0.048, 0.11) Rf — —
Observed air freshener, Observed
candles, Observed incense, Observed
other scented products, Reported air
fresheners, Reported gas pumping








(´0.19, 0.17) Rf — —
Observed air freshener, Observed
candles, Observed incense, Observed
other scented products, Reported air
fresheners, Reported gas pumping




(´0.096, 0.26) Rf Rf
0.02
(´0.058, 0.098) — —
´0.12
(´0.2, ´0.042) * Rf Reported gas pumping
Xylene (2MHA) 0.7 (0.41, 0.99) * ´0.57(´0.71, ´0.43) *
´0.63







Observed air freshener, Observed
candles, Observed incense, Observed
other scented products, Reported
aerosols, Reported air fresheners,
Reported gas pumping
Xylene (3MHA + 4MHA) 1.1 (0.83, 1.4) * ´0.56(´0.7, ´0.42) *
´0.65







Observed air freshener, Observed
candles, Observed incense, Observed
other scented products, Reported
aerosols, Reported air fresheners,
Reported gas pumping
Notes: Parameter estimates not shown for variables that were not significant in any model. * denotes variable significant at p < 0.01. All models included adjustment for visit type
and creatinine.
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4. Discussion
For the first time, data on the variability of the concentration of 22 urinary metabolites of 18 parent
VOCs has been compared with observed and reported sources of exposure to VOCs in a geographically
diverse sample of pregnant women in the United States. In this analysis we compared indirect exposure
measurement methods such as questionnaires and observations of VOC sources in the home with a
more direct exposure measurement method, the measurement of VOC metabolites in urine.
Recently, Jain reported VOC metabolite levels using data from the National Health and Nutrition
Examination Survey (NHANES) 2011–2012 [2,36]. The metabolite detection rate and distribution
presented here is similar to that found in NHANES 2011–2012 [2,36]. As observed in this study and
NHANES, VOC exposure tends to be highly right skewed, and thus VOC exposure biomarkers such as
urinary VOC metabolites are also highly right skewed. For this reason, we model our data using log10
transformed results to achieve more of a normal distribution. Additionally, we present the geometric
mean as the central tendency for summary statistics.
Most of the metabolites were associated with smoking. These findings are not unexpected
because the panel of measurements was designed to measure metabolites of VOCs that are present
in tobacco smoke and thus the same increased exposures have been observed in NHANES [2,3,36].
We did not observe this relationship with smoking for the following metabolites: benzene metabolite
PMA, the benzene metabolite MU, the carbon disulfide metabolite TTCA, the ethylbenzene and
styrene metabolite PHGA, and the toluene metabolite BMA. However, BMA and MU are not specific
biomarkers for tobacco constituents and both can be formed from exposure to benzyl alcohol, and
benzyl acetate in personal care products, and sorbic acid (a food preservative) respectively [37].
Others have found a weak correlation between serum cotinine and TTCA as well as serum cotinine and
PMA [3]. There are several logical reasons for these differences, TTCA is not specific to carbon disulfide
exposure as it is also associated with the consumption of brassica vegetables [38]. PMA is specific to
benzene exposure, but is only a minor benzene metabolite. The relatively low benzene exposures in
this study may not have been of sufficient magnitude to be detected with our method [39,40].
We also observed a near-significant relationship between acrylamide metabolites and incense
and a significant relationship between paint/varnish use and the xylene metabolites, supporting the
use of indirect exposure measures such as questionnaires and observations for exposure to these
chemicals. These associations are not unexpected because xylenes are common components of paints
and paint thinners and acrylamide is a component of incense [41,42]. We did not observe statistically
significant (p < 0.01) relationships between the observation of air fresheners, scented candles, other
scented products, reported average cooking time, reported use of air fresheners and aerosols, and
gas pumping to VOC metabolites in any models (Table 3). Possible explanations for this include: the
products used did not contain VOCs or were made with VOCs we could not detect, the sporadic use
of these products; the short biological half-lives of the VOC metabolites (2.1–34 h) [3]; the fact that
many of the parent compounds having a wide variety of exposure sources; or observations and urine
collection being completed at different visits in most cases.
We expected some relationships between VOC metabolites and the administered questions about
used of scented products. Part of this expectation is based on findings from the Avon Longitudinal
Study of Parents and Children (ALSPAC), which reported a relationship between the mothers’ report
of the use of aerosols and scented products and the concentration of total VOCs in indoor air [43].
However, our analyses are quite different than these ALSPAC findings [43]. We looked at exposure
to individual VOCs by measuring urinary metabolites whereas these ALSPAC findings present total
VOCs in indoor air at multiple time points [43]. Urinary biomarkers represent an individual’s total
exposure to the parent compounds of interest over a short time period, because the half-lives are
roughly 2.1–34 h depending on the compound [3]. The air samples from the ALSPAC study were set
up in the homes for 1 month, and up to 10 samples were received from each home. Since the use of air
fresheners and aerosols may be a regular behavior, but not one that occurs daily, it makes sense that
a relationship would be more likely to be found with an exposure measurement which represents a
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longer time period. Additionally, ALSPAC measured total VOCs using a non-specific method that
would combine all volatiles into one single value, whereas we compared reported use of products with
a selective measure of biomarkers of exposure to 20 targeted VOCs [43].
Exposure assessment using urinary metabolites has limitations, such as the metabolite being
produced from exposure to multiple parent compounds or the metabolite being produced not from a
parent-chemical uptake and metabolism but as a result of uptake of the metabolite from environmental
media [44]. Additionally, within individual variability results from episodic and varied exposures,
and thus, averaging exposure over a longer time frame would likely produce exposure distributions
that are less highly skewed. Differences in metabolism between people may further contribute to
variability, but our experience to date with these VOC metabolites leads us to believe that metabolism
is unlikely to be as important as differences in exposure. Another limitation of our analysis is that
most of the home observations and the question about gas pumping were not completed at the same
point in visit that the urine samples were collected and these behaviors may have changed. Removing
the samples where observations were not completed at the same visit would have severely lowered
our statistical power, as the sample size would have been reduced from 488 to 144. Despite the time
difference between observation completion and biospecimen collection for some study participants,
we did observe one near-significant relationship between acrylamide exposure and the observation
of incense. We also were unable to evaluate many possible factors which could have been related to
some of the VOC sources of interest, such as the possibility of occupational exposures, time spent near
road ways, or home proximity to gas stations. These factors were not evaluated in this study because a
preliminary look at the results of the occupational questions revealed that manufacturing jobs were
not common among women in this dataset and the home and work addresses of NCS participants was
not available.
Concentrations of the toluene metabolite BMA were lower in rural locations than in urban
locations, although the significance of this finding is uncertain given the lack of specificity of the
BMA biomarker. BMA can be formed from multiple sources other than toluene (e.g., benzyl alcohol,
a widespread constituent of cosmetic products including shampoo, creams, after-shave lotions, and
fragrances) [45].
5. Conclusions
Exposure assessment in epidemiological studies is challenging and can be conducted via a variety
of methods. In this analysis, we show that is feasible to assess for exposure to VOCs in pregnant women.
We also observed some associations between indirect VOC exposure measures, use of paint/varnish,
and observation of incense in the home and more direct exposure measure of VOC metabolites in urine.
All of the exposure assessment methods discussed in this paper have unique strengths. Measurements
of exposure in biospecimens can help us estimate internal dose, but only interview and observation
data can inform studies of the likely sources of exposure to these chemicals.
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